Institutional investors purchased a net $930.7 thousand shares of GHDX during the quarter ended December 2014 and now own 95.52% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK ADVISORS LLC Bought 310.5 Thousand shares of Genomic Health Inc
BAKER BROS. ADVISORS LP Bought 205.1 Thousand shares of Genomic Health Inc
BLACKROCK INVESTMENT MANAGEMENT ... Bought 152.6 Thousand shares of Genomic Health Inc